News

Qilu Pharmaceutical launched the first innovative drug in China

ABOUT US

News

Qilu Pharmaceutical launched the first innovative drug in China

Release time：

2023-09-01

Qilu Pharmaceutical launched the first innovative drug in China

On July 12th, 2023, Qilu Pharmaceutical launched the innovative drug Qi Xinke (Iruplinalkib Tablet) in China, this is the first innovative drug launched by Qilu.

Iruplinalkib Tablet is Indicated for the treatment of ALK-positive, locally advanced or metastatic, non-small cell lung cancer (NSCLC) in patients who have disease progression after previous crizotinib treatment or are intolerant to crizotinib.

Qilu Launches First Generic Version of Invega Sustenna® (Paliperidone Palmitate Suspension for Injection) in China

Qilu Pharmaceutical Group Awarded as Socially Responsible Enterprises (Entrepreneurs) in 2022

Related News

Qilu Pharmaceutical ranks No.3 in the list of "Top 100 Enterprises in Chinese Pharmaceutical industry”

2024-09-30

Qilu Launches First Generic Version of Invega Sustenna® (Paliperidone Palmitate Suspension for Injection) in China

2023-10-12

Qilu Pharmaceutical launched the first innovative drug in China

2023-09-01

Qilu Pharmaceutical Group Awarded as Socially Responsible Enterprises (Entrepreneurs) in 2022

2023-04-04

Qilu Pharmaceutical ranks No.5 in the list of "Top 100 Enterprises in Chinese Pharmaceutical Industry”